Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9.

MLA

Liu, Huidi, et al. “Main Components of Pomegranate, Ellagic Acid and Luteolin, Inhibit Metastasis of Ovarian Cancer by down-Regulating MMP2 and MMP9.” Cancer Biology & Therapy, vol. 18, no. 12, Dec. 2017, pp. 990–99. EBSCOhost, https://doi.org/10.1080/15384047.2017.1394542.

APA

Liu, H., Zeng, Z., Wang, S., Li, T., Mastriani, E., Li, Q.-H., Bao, H.-X., Zhou, Y.-J., Wang, X., Liu, Y., Liu, W., Hu, S., Gao, S., Yu, M., Qi, Y., Shen, Z., Wang, H., Gao, T., Dong, L., … Liu, S.-L. (2017). Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9. Cancer Biology & Therapy, 18(12), 990–999. https://doi.org/10.1080/15384047.2017.1394542

Chicago

Liu, Huidi, Zheng Zeng, Siwen Wang, Ting Li, Emilio Mastriani, Qing-Hai Li, Hong-Xia Bao, et al. 2017. “Main Components of Pomegranate, Ellagic Acid and Luteolin, Inhibit Metastasis of Ovarian Cancer by down-Regulating MMP2 and MMP9.” Cancer Biology & Therapy 18 (12): 990–99. doi:10.1080/15384047.2017.1394542.